Anti-IL17B/ IL-17B/ IL-20 functional antibody

Anti-IL17B/ IL-17B/ IL-20 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to IL17B/IL17B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IO076-Ab-1/ GM-Tg-hg-IO076-Ab-2Anti-Human IL17B monoclonal antibodyHuman
GM-Tg-rg-IO076-Ab-1/ GM-Tg-rg-IO076-Ab-2Anti-Rat IL17B monoclonal antibodyRat
GM-Tg-mg-IO076-Ab-1/ GM-Tg-mg-IO076-Ab-2Anti-Mouse IL17B monoclonal antibodyMouse
GM-Tg-cynog-IO076-Ab-1/ GM-Tg-cynog-IO076-Ab-2Anti-Cynomolgus/ Rhesus macaque IL17B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IO076-Ab-1/ GM-Tg-felg-IO076-Ab-2Anti-Feline IL17B monoclonal antibodyFeline
GM-Tg-cang-IO076-Ab-1/ GM-Tg-cang-IO076-Ab-2Anti-Canine IL17B monoclonal antibodyCanine
GM-Tg-bovg-IO076-Ab-1/ GM-Tg-bovg-IO076-Ab-2Anti-Bovine IL17B monoclonal antibodyBovine
GM-Tg-equg-IO076-Ab-1/ GM-Tg-equg-IO076-Ab-2Anti-Equine IL17B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IO076-Ab-1/ GM-Tg-hg-IO076-Ab-2; GM-Tg-rg-IO076-Ab-1/ GM-Tg-rg-IO076-Ab-2;
GM-Tg-mg-IO076-Ab-1/ GM-Tg-mg-IO076-Ab-2; GM-Tg-cynog-IO076-Ab-1/ GM-Tg-cynog-IO076-Ab-2;
GM-Tg-felg-IO076-Ab-1/ GM-Tg-felg-IO076-Ab-2; GM-Tg-cang-IO076-Ab-1/ GM-Tg-cang-IO076-Ab-2;
GM-Tg-bovg-IO076-Ab-1/ GM-Tg-bovg-IO076-Ab-2; GM-Tg-equg-IO076-Ab-1/ GM-Tg-equg-IO076-Ab-2
Products NameAnti-IL17B monoclonal antibody
Formatmab
Target NameIL17B
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-IL17B benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IO076-Ag-1Recombinant multi-species IL17B/ IL-17B/ IL-20 protein
    CytokineGM-Tg-g-IO076-Ag-1interleukin 17B (IL17B) protein


    Target information

    Target IDGM-IO076
    Target NameIL17B
    Gene ID27190,56069,116472,710679,489193,101086204,504992,100060593
    Gene Symbol and Synonyms1110006O16Rik,1700006N07Rik,IL-17B,IL-20,IL17B,NIRF,ZCYTO7
    Uniprot AccessionQ9UHF5
    Uniprot Entry NameIL17B_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target, Immuno-oncology Target, Cytokine Target
    DiseaseLung Cancer
    Gene EnsemblENSG00000127743
    Target ClassificationCheckpoint-Immuno Oncology

    The target: IL17B, gene name: IL17B, also named as IL-17B, IL-20, NIRF, ZCYTO7. The protein encoded by this gene is a T cell-derived cytokine that shares sequence similarity with IL17. This cytokine was reported to stimulate the release of TNF alpha (TNF) and IL1 beta (IL1B) from a monocytic cell line. Immunohistochemical analysis of several nerve tissues indicated that this cytokine is primarily localized to neuronal cell bodies. Alternative splicing results in multiple splice variants. [provided by RefSeq, Dec 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.